Skip to main content
. 2018 Sep 21;8:14161. doi: 10.1038/s41598-018-32256-x

Figure 5.

Figure 5

Vps34 downregulation decreases proliferation of Tsc2-deficient cells in vivo. Mice were injected subcutaneously with 2.5 × 106 Tsc2−/− shCTL or shPI3KC3 MEFs. Mice bearing tumors > 100 mm3 were identified by palpation. (A) Tumor latency was increased in Tsc2−/− shPIK3C3, compared to Tsc2−/− shCTL tumors. Statistical significance was assessed by Mantel-Cox Test with p = 0.001. (B) Tumor volume was decreased in the shPI3KC3 tumors compared to shCTL tumors. (C) Growth of individual shCTL and shPI3KC3 tumors. (D) Tumor volume at 8 days after palpation. Data presented as mean +/− standard deviation. Statistical significance was assessed by Student’s unpaired t-test with *p < 0.05, ****p < 0.0001.